Under our experimental conditions, both FOJ and FOS extracts significantly reduced the cell viability of tested cell lines, although with more selectivity towards MDA-MB-468 breast cancer cells and a higher potency of FOS. The gene discussed is FOS; the disease is breast carcinoma.